Predictors of genetic testing uptake in newly diagnosed breast cancer patients.

ABSTRACT:

Background and objectives

Many newly diagnosed breast cancer patients do not receive genetic counseling and testing at the time of diagnosis. We examined predictors of genetic testing (GT) in this population.

Methods

Within a randomized controlled trial of proactive rapid genetic counseling and testing vs usual care, patients completed a baseline survey within 6 weeks of breast cancer diagnosis but before a definitive survey. We conducted a multinomial logistic regression to identify predictors of GT timing/uptake.

Results

Having discussed GT with a surgeon was a dominant predictor (χ² (2, N = 320) = 70.13; P < .0001). Among those who discussed GT with a surgeon, patients who had made a final surgery decision were less likely to receive GT before surgery co

SUBMITTER: Ladd MK 

PROVIDER: S-EPMC7397428 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature